As of November 2024, Fusion Antibodies has a market cap of $2.59M. This makes Fusion Antibodies the world's 35665th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.25M | -2.59% |
2023 | $3.34M | -90.56% |
2022 | $35.32M | -59.09% |
2021 | $86.33M | -11.29% |
2020 | $97.31M | 57.96% |
2019 | $61.61M | 44.04% |
2018 | $42.77M | -74.41% |
2017 | $167.16M | - |